Associate Professor Georgina Long has won the InStyle Women In Style Award
14 May 2015
Associate Professor Georgina Long of Melanoma Institute Australia (MIA) has won the InStyle Women In Style Awards for the Science and Environment category. Dr Long was nominated by InStyle over 6 months ago and since then there has been a public voting campaign as well as selection by a very high-powered influential panel of women including Jana Wendt, Collette Dinnigan, Nicola Kidman, Deborah Lee Furness and Layne Beachley.
Other nominees for the Science & Environment category were Kirsty Albion and Lucy Manne (Co-Directors Australian Youth Climate Coalition) and Mara Bún (Founder of Green Cross Australia).
Dr Long is a principal investigator in clinical trials of drugs given to patients with early stage melanoma as well as patients with stage four melanoma at MIA. It is through work like this that a “penicillin moment” is emerging in the field of cancer.
“For the first time we are showing that you can harness the immune system to kill cancer cells,” Dr Long explains.
Dr Long was presented with the award at the InStyle event on Wednesday night.
“I know that life is short, I see that in my work, I want to make the most of every day,” said Dr Long in her acceptance speech.
One person still dies from melanoma every 6 hours in Australia and at MIA we are working hard to change this devastating statistic. With your support we can continue to find melanoma breakthroughs that result in life changing results for melanoma patients.
Help us reach our ultimate goal of finding a cure. Donate now.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.